Researchers discovered the FBXW11 protein facilitates ubiquitination of YB1, a key factor in hepatocarcinoma growth suppression. This novel molecular mechanism opens potential therapeutic pathways targeting FBXW11-YB1 interactions in aggressive liver cancers. The findings, published in the Journal of Cancer Research and Clinical Oncology, contribute to expanding precision oncology options for hepatocellular carcinoma patients.